| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-08 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-07 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |